Great Point Partners as of June 30, 2019
Portfolio Holdings for Great Point Partners
Great Point Partners holds 25 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iovance Biotherapeutics (IOVA) | 14.9 | $134M | 5.5M | 24.52 | |
| Zogenix | 10.0 | $91M | 1.9M | 47.78 | |
| Ptc Therapeutics I (PTCT) | 9.9 | $89M | 2.0M | 45.00 | |
| Mirati Therapeutics | 8.9 | $80M | 775k | 103.00 | |
| Audentes Therapeutics | 8.1 | $73M | 1.9M | 37.86 | |
| Kura Oncology (KURA) | 6.7 | $60M | 3.0M | 19.69 | |
| Acceleron Pharma | 6.6 | $60M | 1.4M | 41.08 | |
| Ascendis Pharma A S (ASND) | 6.4 | $58M | 500k | 115.15 | |
| Tricida | 6.2 | $56M | 1.4M | 39.46 | |
| ACADIA Pharmaceuticals (ACAD) | 4.5 | $40M | 1.5M | 26.73 | |
| Biohaven Pharmaceutical Holding | 2.7 | $24M | 550k | 43.79 | |
| Zymeworks | 2.6 | $23M | 1.1M | 22.00 | |
| Retrophin | 2.2 | $20M | 1.0M | 20.09 | |
| Prothena (PRTA) | 2.0 | $18M | 1.7M | 10.57 | |
| Dermira | 1.6 | $15M | 1.6M | 9.56 | |
| Millendo Therapeutics | 1.6 | $15M | 1.3M | 11.56 | |
| Genfit S A ads (GNFT) | 1.5 | $14M | 694k | 19.75 | |
| Menlo Therapeutics | 1.1 | $10M | 1.7M | 5.99 | |
| Foamix Pharmaceuticals | 0.6 | $5.0M | 2.1M | 2.38 | |
| Momenta Pharmaceuticals | 0.5 | $4.3M | 342k | 12.45 | |
| Osmotica Pharmaceuticals (RVLPQ) | 0.4 | $3.5M | 927k | 3.80 | |
| Proteostasis Therapeutics In | 0.4 | $3.4M | 3.5M | 0.98 | |
| Five Prime Therapeutics | 0.4 | $3.3M | 548k | 6.03 | |
| Zafgen | 0.3 | $2.6M | 2.2M | 1.19 | |
| Streamline Health Solutions (STRM) | 0.0 | $197k | 130k | 1.51 |
